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Saccharomyces cerevisiae ERG1 (squalene
epoxidase) mutant and agro-industrial feedstock
Claire M Hull1, E Joel Loveridge2, Nicola J Rolley1, Iain S Donnison3, Steven L Kelly1 and Diane E Kelly1*Abstract
Background: Genetically customised Saccharomyces cerevisiae that can produce ethanol and additional bio-based
chemicals from sustainable agro-industrial feedstocks (for example, residual plant biomass) are of major interest to
the biofuel industry. We investigated the microbial biorefinery concept of ethanol and squalene co-production
using S. cerevisiae (strain YUG37-ERG1) wherein ERG1 (squalene epoxidase) transcription is under the control of a
doxycycline-repressible tet07-CYC1 promoter. The production of ethanol and squalene by YUG37-ERG1 grown using
agriculturally sourced grass juice supplemented with doxycycline was assessed.
Results: Use of the tet07-CYC1 promoter permitted regulation of ERG1 expression and squalene accumulation in
YUG37-ERG1, allowing us to circumvent the lethal growth phenotype seen when ERG1 is disrupted completely. In
experiments using grass juice feedstock supplemented with 0 to 50 μg doxycycline mL−1, YUG37-ERG1 fermented
ethanol (22.5 [±0.5] mg mL−1) and accumulated the highest squalene content (7.89 ± 0.25 mg g−1 dry biomass) and
yield (18.0 ± 4.18 mg squalene L−1) with supplements of 5.0 and 0.025 μg doxycycline mL−1, respectively. Grass juice
was found to be rich in water-soluble carbohydrates (61.1 [±3.6] mg sugars mL−1) and provided excellent feedstock
for growth and fermentation studies using YUG37-ERG1.
Conclusion: Residual plant biomass components from crop production and rotation systems represent possible
substrates for microbial fermentation of biofuels and bio-based compounds. This study is the first to utilise S. cerevisiae
for the co-production of ethanol and squalene from grass juice. Our findings underscore the value of the biorefinery
approach and demonstrate the potential to integrate microbial bioprocess engineering with existing agriculture.
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Microbial biotechnology is employed for the generation
of novel industrial, pharmaceutical and medical com-
pounds and assists in the development of more efficient
commercial production processes. Microorganisms that
possess the enzymatic machinery needed to unlock fuel
energy from cellulosic and lignocellulosic fractions of
plant biomass [1-5] and recombinant strains that can
utilise alternative substrates (such as inulin [6]) for the
production of additional bio-based products [7-10], are
of major interest to biofuel and biorefinery industries. In* Correspondence: D.Kelly@swansea.ac.uk
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unless otherwise stated.the following study we investigated the potential to
co-produce ethanol and squalene using a genetically cus-
tomised strain of S. cerevisiae.
Squalene is a polyunsaturated, triterpenic hydrocar-
bon (2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-
hexaene) with nutritional, cosmetic, pharmaceutical and
medical applications [11-14]. As a key intermediate of
bacterial hopanoid and eukaryotic sterol biosynthesis
[15,16], squalene is ubiquitous in nature. Squalene can
be derived from plant oils [17,18] and the liver oil of
deep sea sharks [19,20]. However, given the increasing
commercial demand for squalene alongside growing
international concern for the fate of food crops and
the exploitation of marine habitats, sustainable sources
of squalene are required.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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tions that affect sterol biosynthesis [21-24] has highlighted
the scope to utilise the brewing yeast S. cerevisiae for
squalene production [25-27,16]. Under low oxygen or an-
aerobic conditions [28,29] and in heme-deficient yeast [30],
squalene accumulates (≥70% of total squalene fraction) in
intracellular lipid droplets [16,31]. However, under aerobic
growth conditions squalene is converted to ergosterol
through the action of proteins encoded by the ERG (ergos-
terol biosynthetic) genes [23]. Of these, squalene epoxidase,
encoded by ERG1 [32,33] is an oxygen-requiring enzyme
[34] that is essential for the initial conversion of squalene to
squalene epoxide (Figure 1).
We investigated the potential to produce squalene as a
bio-based chemical product of yeast fermentation using
a customised S. cerevisiae strain (YUG37-ERG1) wherein
ERG1 gene transcription is under the control of aFigure 1 Ergosterol biosynthetic pathway in yeast. Structures of squale
enzymatic step; broken arrow =multiple enzymatic steps. Gene names aredoxycycline-repressible promoter that replaces the ERG1
promoter at the chromosomal locus [35,36]. Because low
growth temperature and decreased oxygen availability are
favourable for both ethanol fermentation and the inhib-
ition of yeast squalene epoxidase [29,34], we envisaged the
opportunity to co-produce ethanol and squalene using a
biorefinery approach. For this purpose we utilised juice ex-
tracted from perennial ryegrass (Lolium perenne) [37,38].
Grass juice represents one of several fractions from
L. perenne biomass that are currently under investigation
as feedstock for biofuel production and microbial biopro-
cess engineering in the United Kingdom [39-41]).
Methods
Yeast strains and growth media
Squalene production studies were undertaken using a la-
boratory strain of Saccharomyces cerevisiae (YUG37-ERG1)ne and selected sterol intermediates (boxed); unbroken arrow = single
upper case, italicised; protein names are lower case, regular.
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is controlled using a previously optimised doxycycline-
repressible tet07-CYC1 promoter system [35,36,42]. The
wild-type S. cerevisiae parent strain (YUG37; Hegemann,
J., unpublished) was used as a comparator during initial
experiments. Both strains were routinely maintained on
yeast-peptone-dextrose (YPD) medium containing (w/v):
2% glucose, 2% Bacto Peptone and 1% yeast extract -
including 2% agar when required (all media components
supplied by Difco).
For ethanol and squalene co-production experiments,
grass juice (GJ) feedstock was extracted from ryegrass
Lolium perenne supplied by the Institute of Biological,
Environmental Research and Rural Sciences (IBERS,
UK) as described previously [37]. GJ was screened to re-
move large particulates, autoclaved (121°C, 30 min) and
frozen (-80°C) prior to use as a growth and fermentation
substrate. All other chemicals used in this study were
supplied by Sigma unless otherwise stated.
Gas chromatography-mass spectrometry (GC-MS) sterol
analysis
Cell pellets from experimental cultures were resus-
pended in 7:3 methanol:water containing 18% (w/v)
potassium hydroxide, 0.1% (w/v) pyrogallol and 10 μg
cholesterol (as the internal standard), and heated at 90°C
for 2 h. Non-saponifiable lipids (squalene and sterols)
were extracted into glass HPLC vials using 3 × 2 mL
hexane. Extracts were evaporated to dryness using a cen-
trifugal evaporator (Heto Maxi dry plus) and derivatised
using 100 μL N,O-bis(trimethylsilyl)trifluoroacetamide
and trimethylchlorosilane (BSTFA-TMCS [99:1]) and
50 μL anhydrous pyridine at 70°C for 2 h [43]. Tri-
methylsilyl (TMS)-derivatised sterols were analysed using a
7890A GC-MS system (Agilent Technologies) with a DB-
5MS fused silica column (30 m× 0.25 mm× 0.25 μm film
thickness; J & W Scientific). The oven temperature was ini-
tially held at 70°C for 4 min, then increased at 25°C min−1
to a final temperature of 280°C, which was held for a
further 25 min. Samples were analysed in splitless mode
(1 μL injection volume) using helium carrier gas, electron
impact ionization (ion source temperature of 150°C) and
scanning from m/z 40 to 850 [44].
GC-MS data files were analysed using MSD Enhanced
ChemStation software (Agilent Technologies Inc.) to
determine squalene and sterol profiles for all isolates
and for derivation of integrated peak areas. Sterols were
identified by reference to retention times and mass frag-
mentation patterns for known standards.
Sterol analysis of strains
Initial experiments were undertaken to determine the ef-
fect of doxycycline on the growth and sterol composition
of the wild-type YUG37 parent and doxycycline-repressibleYUG37-ERG1 strain. Single colonies from each were used
to inoculate 10-mL volumes of YPD medium (containing 0
to 50 μg doxycycline mL−1) with starting cell densities of
5 × 105 mL−1. Cultures were grown in 50-mL flasks at
30°C, 180 rpm for 48 h, after which time the cell bio-
mass was harvested by centrifugation. Cell pellets were
dried to constant mass for biomass (g dry weight L−1)
determinations, and the cellular squalene and sterol con-
tent determined by GC-MS as described above.
Production of ethanol and squalene from GJ feedstock
Simultaneous co-production
Experiments to achieve simultaneous co-production of
ethanol and squalene were performed in 100-well honey-
comb microplates using a Bioscreen C (Oy Growth
Curves Ab Ltd, Finland). Uniform starting (t0h) cul-
ture densities were achieved by resuspending a single
YUG37-ERG1 colony in GJ and diluting to obtain
5 × 105 cells mL−1 in 1 mL of GJ containing 0 to
50 μg doxycycline mL−1. Starting cultures were vor-
texed and aliquoted into Bioscreen wells (3 × 300 μL
replicates per doxycycline treatment). All experiments
were incubated at 20°C (typical of ale production) in
the Bioscreen (no shaking regime) for 96 h, with optical
density readings (at 600 nm) taken every 45 min [31].
Data was exported from the Bioscreen in ASCII format
prior to analysis using Excel (Microsoft Office 2003).
Dry weight determinations and GC-MS sterol analyses
were performed on the biomass fractions from pooled
Bioscreen wells.
Growth parameters were derived as described previ-
ously [38]. Briefly, ΔOD values describe maximum OD
minus minimum OD; the lag phase is defined as the
length of time a culture spends at <10% of maximum
OD; T½Max values are equivalent to the time taken to
reach half the maximum increase in growth of a culture
(ΔOD × 0.5). Minimum (that is, fastest) doubling times
(DTmin) were estimated by dividing the natural loga-
rithm of 2 by the fastest culture growth rates (μ), where
μ is the gradient of the linear trend line fitted to log-
transformed OD data.
Sequential production
The stepwise production of ethanol and squalene was
monitored using the Bioscreen. YUG37-ERG1 was first
grown for 48 h at 20°C using GJ feedstock; at t48h Biosc-
reen measurements were suspended and 100 μL of
supernatant removed from experimental wells for etha-
nol analysis [38]. This volume was immediately replaced
with 100 μL of fresh GJ containing doxycycline (to give
a final concentration of 5 or 50 μg doxycycline mL−1)
and the Bioscreen restarted using a medium shaking
regime to promote new growth and squalene accu-
mulation. Dry weight determinations and GC-MS sterol
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pooled Bioscreen wells at t96h.
Sugar and ethanol assays
At specific time intervals (t0h, t48h, t72h and t96h) Biosc-
reen measurements were suspended and a 10-μL volume
of culture supernatant removed from representative ex-
perimental wells for ethanol and sugar analyses.
Sugar analyses were performed on suitably diluted
(typically 2,500-fold) culture medium in 100 mM potas-
sium phosphate, pH 7.0, containing 10 mM MgSO4, 1 mM
NAD+, 1.5 mM ATP and 20 U mL−1 Leuconostoc mesen-
teroides glucose-6-phosphate dehydrogenase (Worthington
Biochemical Corporation). Concentrations of glucose,
fructose, sucrose and fructan were determined from
the changes in absorbance at 340 nm following se-
quential addition of 20 U mL−1 S. cerevisiae hexokinase
(Worthington Biochemical Corporation), 20 U mL−1 E. coli
phosphoglucose isomerase (Megazyme International
Ireland Ltd), 1.5 U mL−1 S. cerevisiae sucrase/maltase
(Megazyme International Ireland Ltd) and 10 U mL−1 fruc-
tanase from Aspergillus niger (Megazyme International
Ireland Ltd), respectively. Standards of glucose, fructose, su-
crose and chicory inulin were used to calibrate the assay.
Ethanol determinations were made using a spectro-
photometric ethanol assay kit (K-ETOH 11/06; Megazyme
Ltd) according to manufacturer’s instructions. All sam-
ples were diluted 1,000-fold with distilled water prior to
analysis.
Results and discussion
Of the many microorganisms that could be employed
for ethanol production, S. cerevisiae remains the species
of choice in industrial-scale fermentation processes [45].Table 1 Phenotypic sterol analysis of YUG37 parent and YUG
DOX Sterol composition (mg sterol g−1)
(μg mL−1) Strain a14α-DM b14α-M Ergoste
0 YUG37 1.45 [0.27] 0.33 [0.03] 3.27 [0.3
YUG37-ERG1 1.51 [0.29] 0.39 [0.07] 3.08 [029
0.025 YUG37 1.30 [0.16] 0.20 [0.06] 3.09 [0.3
YUG37-ERG1 1.55 [0.09] 0.40 [0.03] 2.43 [0.0
0.05 YUG37 1.47 [0.22] 0.26 [0.03] 3.03 [0.1
YUG37-ERG1 0.78 [0.10] 0.40 [0.08] 2.20 [0.0
0.5 YUG37 1.36 [0.22] 0.24 [0.06] 2.79 [0.3
YUG37-ERG1 0.45 [0.01] 0.17 [0.02] 1.58 [0.1
5 YUG37 1.54 [0.29] 0.29 [0.06] 3.06 [0.4
YUG37-ERG1 0.21 [0.04] 0.08 [0.04] 1.49 [0.0
50 YUG37 1.21 [0.23] 0.23 [0.01] 2.93 [0.2
YUG37-ERG1 0.11 [0.03] 0.02 [0.01] 1.50 [0.0
All cultures grown at 30°C, 180 rpm for 48 h on YPD medium. Mean values (n = 3 [±SD])
a = sum of all 14α-demethylated sterols; b = sum of 14α-methylated sterols.Similarly, whilst squalene could be sourced from alterna-
tive microbes ([16,27] for reviews), because of the need
for specific culture conditions and because many have
not been granted GRAS (generally regarded as safe) sta-
tus, they cannot be exploited in a commercial setting.
The present study is the first to utilise S. cerevisiae for
the co-production of ethanol and squalene from a single
feedstock. We identify clear avenues for the integration
of yeast biotechnology and existing agriculture for the
production of bio-based compounds, thereby adding
value to such fermentations.
Regulation of growth and squalene accumulation
Data from initial experiments using YPD medium (Table 1)
demonstrate the potential to maximise squalene produc-
tion from S. cerevisiae through regulation of ERG1 expres-
sion (Figure 1) and indicate that in order to achieve an
optimal squalene yield, repression of ERG1 gene expression
must be sufficient to result in increased squalene accumu-
lation, but not complete growth inhibition. The highest
squalene content (7.85 ± 0.02 mg g−1 dry biomass) was re-
corded in YUG37-ERG1 grown using YPD supplemented
with 50 μg doxycycline mL−1; however, because the bio-
mass of these cultures was low (1.39 ± 0.12 mg L−1), the
squalene titre was sub-optimal (10.87 ± 0.93 mg L−1). Con-
versely, whilst the squalene content of YUG37-ERG1
grown with 0.025 μg doxycycline mL−1 was comparatively
lower (3.57 ± 0.2 mg g−1 dry biomass), higher overall cul-
ture growth (4.3 ± 0.28 mg L−1) supported an improved
squalene titre (Table 1; 15.04 ± 1.42 mg L−1).
Alterations in yeast sterol composition
Doxycycline did not alter the sterol composition of
the YUG37 parent across the range of doxycycline37-ERG1 mutant
Total Biomass Squalene titre
rol Squalene (mg g−1) (g L−1) (mg L−1)
9] 0.16 [0.08] 5.31 [0.19] 3.75 [0.35] 0.50 [0.11]
] 0.40 [0.03] 5.28 [0.24] 4.55 [0.21] 1.76 [0.02]
5] 0.17 [0.13] 4.75 [0.02] 4.25 [0.21] 0.55 [0.31]
8] 3.57 [0.20] 7.88 [0.31] 4.30 [0.28] 15.04 [1.42]
4] 0.30 [0.04] 4.98 [0.19] 3.90 [0.14] 1.23 [0.03]
9] 4.24 [0.30] 7.55 [0.33] 2.50 [0.28] 10.31 [0.79]
2] 0.23 [0.06] 4.77 [0.30] 3.95 [0.07] 1.02 [0.14]
2] 6.75 [0.20] 8.96 [0.06] 1.75 [0.21] 11.93 [1.27]
2] 0.20 [0.10] 5.03 [0.11] 3.60 [0.42] 0.57 [0.12]
2] 7.66 [0.01] 9.45 [0.08] 1.48 [0.11] 11.30 [0.82]
6] 0.14 [0.06] 4.63 [0.27] 3.75 [0.35] 0.59 [0.05]
3] 7.85 [0.02] 9.48 [0.10] 1.39 [0.12] 10.87 [0.93]
; DOX = doxycycline. Maximum squalene content and yield are emboldened.
Figure 2 Relative (%) abundance of sterols in YUG37 (open
bars) and YUG37-ERG1 (filled bars) cultured using YPD; mean
values (n = 2 [±SD]). A = squalene; B = ergosterol; C = sum of all
14α-demethylated sterols; D = sum of 14α-methylated sterols.
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no significant differences in the proportion of 14α-
demethylated or 14α-methylated sterol intermediates
were detected in treated YUG37 cultures (Figure 2C
and 2D) indicates that doxycycline did not affect the
function of other ERG genes or proteins involved in er-
gosterol biosynthesis (Figure 1). Changes in the sterol
composition of doxycycline-treated YUG37-ERG1 cul-
tures, namely overall decreases in both 14α-demethylated
and 14α-methylated sterol intermediates, are consistent
with the specific inhibition of squalene epoxidase expres-
sion. Enhanced accumulation of squalene at the expense
of other sterol intermediates has previously been re-
ported in S. cerevisiae treated with the squalene epoxi-
dase inhibitor, terbinafine [27].
Growth and ethanol fermentation: grass juice feedstock
Growth parameters for YUG37-ERG1 grown using grass
juice (GJ) (Table 2 and Figure 3) underscore data from
previous studies that highlight its potential as a feed-
stock for S. cerevisiae [37,38]. GJ was rich in water-
soluble carbohydrates (Table 3) that were readily utilised
for growth and ethanol fermentation. In simultaneous
ethanol and squalene production experiments, max-
imum concentrations of ethanol (20 to 23 mg mL−1)
were produced after 72 h of fermentation. Similar con-
centrations (22.5 [±0.5] mg ethanol mL−1) were recorded
in sequential production experiments (Table 4, aster-
isked data) after just 48 h, prior to the addition of doxy-
cycline. Taken as a whole, the ethanol titres in this
study are comparable to those achieved previously
using GJ and alternative wild-type laboratory strains of
S. cerevisiae [37,38].
Ethanol titres
High ethanol titres have recently been achieved using
pure inulin and soybean feedstock and an engineered
yeast strain (Saccharomyces sp. W0) expressing the
inulinase gene from Pichia guilliermondii [10]. Work
is now needed to address the potential to use recom-
binant yeast to ferment grass juice to ethanol on an
industrial scale and alternative (for example, floccu-
lating [46-48] or high ethanol producing [10] host strains
of S. cerevisiae.
Squalene accumulation: grass juice feedstock
The highest squalene content (7.89 ± 0.25 mg g−1 dry
biomass) and squalene titres (18.0 ± 4.18 mg L−1) were
achieved during simultaneous production experiments
in which GJ was supplemented (at t0h) with 5 and
0.025 μg doxycycline mL−1, respectively (Table 4 and
Figure 4). In subsequent experiments the highest total
biomass (5.2 to 5.4 g L−1) was recorded 48 h after the re-
moval of culture supernatant and the addition of freshdoxycycline-supplemented GJ (Table 4, asterisked data).
However, concomitant with the accumulation of ergos-
terol during initial growth in the absence of doxycycline
Table 2 Growth parameters for YUG37-ERG1 cultured on
GJ at 20°C in the Bioscreen
DOX
ΔOD Lag phase (h) T½Max (h) DTmin (h)
(μg mL−1)
0 1.69 [0.01] 11.3 [0.4] 21.8 [0.4] 3.8 [0.4]
0.025 1.66 [0.01] 11.4 [0.2] 22.6 [0.5] 4.3 [0.1]
0.05 1.63 [0.01] 11.5 [0.4] 24.1 [1.2] 5.4 [0.2]
0.1 1.54 [0.01] 11.5 [0.7] 28.9 [0.9] 6.0 [0.7]
0.5 1.43 [0.02] 11.8 [0.4] 31.5 [0.7] 8.6 [0.5]
1 1.34 [0.02] 11.5 [0.4] 35.8 [0.4] 10.3 [0.4]
5 1.35 [0.01] 11.5 [0.7] 38.0 [2.8] 10.3 [0.7]
50 1.34 [0.02] 10.9 [0.5] 37.0 [1.4] 10.4 [0.9]
Mean values (n = 3 [±SD]). DOX = doxycycline; ΔOD=maximum minus minimum
optical density reading at 600 nm; Lag phase = length of time culture remains
at < 10% of maximum OD; T½Max = time taken to achieve half maximal culture
growth (maximum OD minus minimum OD× 0.5); DTmin = fastest observed
doubling time.
Table 3 Glucose, fructose, sucrose and fructan content of
GJ media during fermentation with YUG37-ERG1
Content in medium (mg mL−1)
Sugar GJ t0 GJ t48 GJ t96 GJ
0.5 t96 GJ
50 t96
Glucose 7.3 [1.8] 0.2 [0.2] — — —
Fructose 22.2 [2.0] 0.4 [0.1] 0.5 [0.1] 0.8 [0.5] 0.6 [0.1]
Sucrose 0.5 [0.3] 0.2 [0.2] 0.1 [0.2] 0.2 [0.2] 0.7 [0.2]
Fructan 31.2 [2.4] 17.8 [0.5] 17.4 [0.04] 17.8 [1.2] 15.7 [2.9]
Total 61.1 [3.6] 18.5 [0.9] 18.1 [0.2] 18.9 [1.4] 16.9 [2.9]
Mean values (n = 2 [±SD]). Superscripts 0.5 and 50 refer to media containing
0.5 and 50 μg mL−1 doxycycline, respectively; Strikethrough = not detected.
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mass) squalene titres (12.0 ± 1.83 and 12.7 ± 0.24 g squa-
lene L−1, respectively) were lower than those recorded in
simultaneous production experiments in which doxycyc-
line was present from t0h. The use of bioreactors to
maintain optimal growth and fermentation conditions
for ethanol and squalene co-production using YUG37-
ERG1 is now an avenue for bioprocess development and
commercial scale-up.Figure 3 Bioscreen growth curves for YUG37-ERG1 at 20°C on
GJ feedstock. Legend indicates concentration of doxycycline
(μg mL−1); curves for 5 and 50 μg mL−1 overlap.Advantages of the doxycycline-regulatable
promoter system
The maximum squalene titres achieved using GJ in the
present study are comparable to those recently reported
for S. cerevisiae grown on standard yeast media in the
presence of the squalene epoxidase inhibitor, terbinafine
[27]. However, in that study a terbinafine concentration
of 300 μM was required to produce the optimum squa-
lene titre (20.70 ± 1.00 mg L−1). In our work, a compar-
able squalene titre was achieved by repressing overall
ERG1 gene transcription with just 0.025 μg mL−1
(0.05 μM) doxycycline (Table 4). In addition to its sensi-
tivity, use of the promoter system to attenuate squalene
epoxidase synthesis at the ERG1 gene level circumvents
the potential to select for protein-level mutations that
conserve squalene epoxidase function (that is, normal
ergosterol biosynthesis) in yeast cultures treated with
protein inhibitors (for example, terbinafine [27]). Terbina-
fine resistant S. cerevisiae harbouring single amino acid
substitutions in the Erg1 protein (either L251F, F402L,
F420L or P430S) have already been reported [49]. The
economic feasibility of using the tet07-CYC1 promoter
system to harness squalene production on an industrial
scale is currently being assessed. Owing to the demand
and high commercial value of squalene, it is anticipated
that the costs of doxycycline supplementation would likely
be offset by those recovered from squalene production.
The design and use of alternative yeast promoter systems
(such as GAL1, CUP1 and MET3 [[50] for summary]) is
possible. However, it is important that the promoter of
choice does not have an effect on yeast physiology, and
that is what is so attractive about the doxycycline system.
Grass biomass and microbial bioprocess engineering
Grass biomass comprises several fractions (for example,
water-soluble sugars, fructans, hemicellulose, cellulose
[39]) that could be used as substrates for the production
of biofuels and other value-added bio-based compounds.
In the present study, 55% of the original fructan was still
present in grass juice at the end of the fermentation
Table 4 Sterol composition, dry weight biomass and squalene titre of YUG37-ERG1 cultured using GJ
DOX Sterol composition (mg sterol g−1) Total Biomass Squalene titre
(μg mL−1) a14α-DM b14α-M Ergosterol Squalene (mg g−1) (g L−1) (mg L−1)
0 1.09 [0.23] 0.47 [0.16] 3.51 [0.83] 0.19 [0.09] 5.25 [0.35] 4.80 [0.28] 0.88 [0.39]
0.025 0.97 [0.46] 0.27 [0.27] 2.64 [0.40] 3.98 [0.68] 7.85 [0.35] 4.50 [0.28] 18.0 [4.18]
0.05 0.73 [0.21] 0.28 [0.17] 2.00 [0.34] 5.14 [0.25] 8.15 [0.21] 2.25 [0.21] 11.5 [0.53]
0.5 0.31 [0.07] 0.09 [0.01] 2.63 [0.48] 5.92 [0.27] 8.95 [0.15] 1.78 [0.11] 10.5 [1.11]
5 0.10 [0.01] 0.01 [0.01] 1.27 [0.15] 7.89 [0.25] 9.28 [0.11] 1.44 [0.04] 11.4 [0.70]
50 — — 1.31 [0.46] 7.84 [0.25] 9.15 [0.21] 1.45 [0.07] 11.4 [0.20]
**5 — — 4.34 [0.07] 2.22 [0.28] 6.55 [0.35] 5.40 [0.14] 12.0 [1.83]
**50 — — 3.80 [0.37] 2.45 [0.02] 6.25 [0.35] 5.20 [0.14] 12.7 [0.24]
All cultures maintained at 20°C in the Bioscreen. Mean values (n = 3 [±SD]); DOX = doxycycline. Maximum squalene content and titre are emboldened. Asterisks
indicate sequential production experiments supplemented with additional GJ + DOX after 48 h growth in the absence of DOX.
Strikethrough = not detected.
a = sum of all 14α-demethylated sterols; b = sum of 14α-methylated sterols.
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http://www.biotechnologyforbiofuels.com/content/7/1/133experiments (Table 3). The enzymatic hydrolysis of fruc-
tans in grass juice prior to yeast fermentation experi-
ments has already been reported [37] and recombinant
yeast that can simultaneously saccharify and ferment
grass fructans to ethanol has recently been achieved
[38]. Because simultaneous saccharification and fermen-
tation requires fewer steps than enzyme addition, we en-
visage further modification of YUG37-ERG1 to enable
utilisation of fructan; this could enhance the efficiency
and yields of ethanol and squalene produced from grass
juice. Use of alternative yeast species (for example, S.
kudriavzevii [51]) and existing recombinant industrialFigure 4 GC-MS analysis of YUG37-ERG1. A) and B) Total ion chromatogra
respectively. 1 = ergosterol; 2 = lanosterol; 3 = squalene. C) and D) Fragmentat
(MSD ChemStation NIST/EPA/NIH Mass Spectral Library Version 2.0).strains (for example, see [52]) that can utilise alternative
substrates and agro-industrial feedstocks for the produc-
tion of squalene and ethanol is also of interest.
Conclusion
Results from this study clearly demonstrate proof of
principle that squalene production can be harnessed
in S. cerevisiae by repressing ERG1 gene transcription.
The potential to co-produce ethanol and squalene
(and/or additional bio-based products) from a single
feedstock using yeast is realistic and warrants further
investigation.ms for YUG37-ERG1 grown on GJ and on GJ + 50 μg doxycycline mL−1,
ion patterns for TMS-derivatised ergosterol and squalene, respectively
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